Normand Balthazard
Chief Executive Officer at Prognomix, Inc.
Normand Balthazard active positions
Companies | Position | Start | End |
---|---|---|---|
Origenix Technologies, Inc. | Corporate Officer/Principal | - | - |
Intellivax International, Inc.
Intellivax International, Inc. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, Intellivax International, Inc. is a Canadian company that develops nasal spray vaccines. The company is based in Laval, Canada. The company was founded by George H. Lowell. Intellivax International was acquired by ID Biomedical Corp., part of GSK Plc from December 13, 2005 on May 16, 2001 for $15.44 million. | Corporate Officer/Principal | - | - |
Prognomix, Inc.
Prognomix, Inc. Pharmaceuticals: GenericHealth Technology Prognomix, Inc. develops market molecular diagnostic kits for testing of diabetes complications. Its products include PGX IR01, PGx GR01, PGx CD01 and PGx IR02. The firm focuses on discovery and clinical application of genomic signatures predictive of susceptibility to diseases, their complications and individual therapeutic responsiveness. The company was founded by Johanne Tremblay and Pavel Hamet in 2005 and is headquartered in Montreal, Canada. | Chief Executive Officer | - | - |
Career history of Normand Balthazard
Former positions of Normand Balthazard
Companies | Position | Start | End |
---|---|---|---|
SAVARIA CORPORATION | Director/Board Member | 28/02/2003 | 28/02/2010 |
Contact Image Corp.
Contact Image Corp. Commercial Printing/FormsCommercial Services Contact Image Corp. provides digital and fabric printing services. It offers a range of printing services including fabric printing, textile printing, and media printing services. The company was founded in 1979 and is headquartered in Ville Mont-Royal, Canada. | Chairman | 31/10/2004 | 22/03/2007 |
President | 31/10/2004 | 22/03/2007 | |
Corporate Secretary | 31/10/2004 | 22/03/2007 | |
Treasurer | 31/10/2004 | 22/03/2007 | |
BioCapital Investment Advisors, Inc.
BioCapital Investment Advisors, Inc. Investment ManagersFinance Montréal-based BioCapital Investment Advisors, Inc. manages the BioCapital health technology mutual fund family. | Analyst-Equity | 16/04/2002 | 30/12/2005 |
Chief Investment Officer | 16/04/2002 | 30/12/2005 | |
Portfolio Manager-Equities | 16/04/2002 | 30/12/2005 | |
President | 16/04/2002 | 30/12/2005 | |
Biorthex, Inc.
Biorthex, Inc. Medical SpecialtiesHealth Technology Biorthex, Inc. designs, develops, manufactures, and markets surgical products for the treatment of spinal disorders. Its products include Actipore PLFx, PLF, and ACF systems. The company was founded by Charles H. Rivard on November 9, 1993 and is headquartered in Laval, Canada. | Corporate Officer/Principal | - | - |
CryoCath Technologies, Inc.
CryoCath Technologies, Inc. Medical SpecialtiesHealth Technology CryoCath Technologies, Inc. manufactures medical equipment. The company was founded by Normand Balthazard and Andre L. Lamotte in 1994 and is headquartered in Montreal, QC. | Founder | - | - |
ConjuChem, Inc.
ConjuChem, Inc. Pharmaceuticals: MajorHealth Technology ConjuChem, Inc. is a biotechnology company that has developed the Drug Affinity Complex (DAC™) Technology, a platform enabling the rapid creation of improved, patentable drugs from existing small organic compounds or peptides. | Corporate Officer/Principal | - | - |
Statistics
International
Canada | 9 |
United States | 2 |
Operational
Corporate Officer/Principal | 4 |
President | 2 |
Analyst-Equity | 1 |
Sectoral
Health Technology | 6 |
Consumer Durables | 2 |
Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
SAVARIA CORPORATION | Consumer Durables |
Private companies | 8 |
---|---|
CryoCath Technologies, Inc.
CryoCath Technologies, Inc. Medical SpecialtiesHealth Technology CryoCath Technologies, Inc. manufactures medical equipment. The company was founded by Normand Balthazard and Andre L. Lamotte in 1994 and is headquartered in Montreal, QC. | Health Technology |
ConjuChem, Inc.
ConjuChem, Inc. Pharmaceuticals: MajorHealth Technology ConjuChem, Inc. is a biotechnology company that has developed the Drug Affinity Complex (DAC™) Technology, a platform enabling the rapid creation of improved, patentable drugs from existing small organic compounds or peptides. | Health Technology |
Biorthex, Inc.
Biorthex, Inc. Medical SpecialtiesHealth Technology Biorthex, Inc. designs, develops, manufactures, and markets surgical products for the treatment of spinal disorders. Its products include Actipore PLFx, PLF, and ACF systems. The company was founded by Charles H. Rivard on November 9, 1993 and is headquartered in Laval, Canada. | Health Technology |
BioCapital Investment Advisors, Inc.
BioCapital Investment Advisors, Inc. Investment ManagersFinance Montréal-based BioCapital Investment Advisors, Inc. manages the BioCapital health technology mutual fund family. | Finance |
Intellivax International, Inc.
Intellivax International, Inc. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, Intellivax International, Inc. is a Canadian company that develops nasal spray vaccines. The company is based in Laval, Canada. The company was founded by George H. Lowell. Intellivax International was acquired by ID Biomedical Corp., part of GSK Plc from December 13, 2005 on May 16, 2001 for $15.44 million. | Health Technology |
Contact Image Corp.
Contact Image Corp. Commercial Printing/FormsCommercial Services Contact Image Corp. provides digital and fabric printing services. It offers a range of printing services including fabric printing, textile printing, and media printing services. The company was founded in 1979 and is headquartered in Ville Mont-Royal, Canada. | Commercial Services |
Prognomix, Inc.
Prognomix, Inc. Pharmaceuticals: GenericHealth Technology Prognomix, Inc. develops market molecular diagnostic kits for testing of diabetes complications. Its products include PGX IR01, PGx GR01, PGx CD01 and PGx IR02. The firm focuses on discovery and clinical application of genomic signatures predictive of susceptibility to diseases, their complications and individual therapeutic responsiveness. The company was founded by Johanne Tremblay and Pavel Hamet in 2005 and is headquartered in Montreal, Canada. | Health Technology |
Origenix Technologies, Inc. |
- Stock Market
- Insiders
- Normand Balthazard
- Experience